Westhouse Medical Services Plc Launches to Drive Effectiveness and Increase Quality in Primary Healthcare Provision

LONDON, October 27, 2011 /PRNewswire/ --

Lists on Open Standard Section of Frankfurt Stock Exchange

Westhouse Medical Services Plc today launches by listing in the Open Standard Section of the Frankfurt Stock Exchange (Ticker Code 5WM). Westhouse Medical is a specialist creating value for investors, providers and patients by delivering step changes in the effectiveness and quality of healthcare delivery.

The newly-formed company does this through identifying and commercialising innovative medical technologies and improving the performance of patient care service businesses in high growth primary healthcare sectors that are open to competitive tender. Westhouse Medical currently consists of two wholly-owned subsidiaries: Medical Services; and Medical Devices.  The company plans to grow further through the acquisition and expansion of other healthcare businesses within Europe and North America.

Patient transfer and breast screening

Westhouse' s Medical Services subsidiary currently provides transport and ambulance services for the NHS in the UK, including specialist bariatric (obese), high dependency and Intensive Treatment Unit patient transfers, whilst the company's Medical Devices division is developing new cost-effective breast cancer screening technology for both domestic and hospital use, due to reach the market in 2012.

Experienced management team

Westhouse Medical's management team is led by chief executive Jack Kaye, who brings over 35 years of technology commercialisation and service business expertise to the company.   Kaye established one of the world's first mobile phone network resellers, which was sold on to form the basis of the Orange mobile phone network in the UK. With extensive experience launching and developing successful businesses, Kaye continues to hold executive positions on the board of both private and publicly quoted companies around the world.

Managing director of the Medical Services subsidiary, Stewart Lawson, has been the driving force behind the market success of AST Ambulance Services, acquired by Westhouse Medical. Within six months under Lawson's management as operations director, AST experienced 36 per cent growth in turnover and quickly became profitable. AST is a market leader in the UK private ambulance services sector.

Demand for primary healthcare services will continue to rise

Jack Kaye, chief executive for Westhouse Medical Services Plc comments: "Demand for primary healthcare services worldwide will continue to rise and healthcare managers and professionals will come under increased pressure to demonstrate efficiency in their purchasing and delivery of within their budgets.   Against this background, there are inexorable changes taking place that put mounting pressure on healthcare providers: growing populations; social mobility; ageing communities; increasing obesity; and climbing expectations of healthcare services and of positive outcomes.

"In such an environment it is essential that new ways are found to simultaneously increase the efficiency and quality of primary healthcare provision both in the private and public sector. This will involve private-sector investment and expertise.  That's why Westhouse Medical is building a balanced portfolio of pre-and post-revenue businesses that will both develop and deliver medical technologies and patient services."

Kaye continues: "Westhouse Medical understands how to create value for investors, service providers and patients through delivering improved effectiveness and quality in primary healthcare. The appointment of the managing director of the Medical Devices subsidiary will be announced shortly."

About Westhouse Medical

Westhouse Medical Services Plc creates value for investors, providers and patients by delivering step changes in the effectiveness and quality of healthcare delivery.

Listed in the Open Section of the Frankfurt Stock Exchange  (Ticker code 5WM), Westhouse Medical is currently composed of two wholly-owned subsidiaries; Medical Services, providing specialist patient transfer and ambulance services; and Medical Devices, which is developing innovative new cost-effective healthcare technologies, including new breast cancer screening devices.

Westhouse Medical Services PLC plans to grow through the acquisition and development of other leading medical businesses within Europe and North America, under the leadership of CEO Jack Kaye - who brings over 35 years of global technology and services business management expertise to the company.  

Westhouse Medical - Primary Healthcare Effectiveness Delivered.